Thomson Medical Group Ltd. (SG:A50) has released an update.
Thomson Medical Group reported stable revenue in Singapore over the past years, with a slight decline to $200.2 million in FY2024 due to the end of certain project-related services. Despite these challenges, the company has maintained its market position and is adjusting strategies in response to the changing healthcare landscape.
For further insights into SG:A50 stock, check out TipRanks’ Stock Analysis page.